Invention Application
- Patent Title: Compounds for the Treatment of Metabolic Disorders
- Patent Title (中): 化合物治疗代谢紊乱
-
Application No.: US13255536Application Date: 2010-03-12
-
Publication No.: US20120040953A1Publication Date: 2012-02-16
- Inventor: Oscar Barba , Susan Helen Davis , Matthew Colin Thor Fyfe , Revathy Perpetua Jeevaratnam , Karen Lesley Schofield , Thomas Staroske , Alan John William Stewart , Simon Andrew Swain , David Matthew Withall
- Applicant: Oscar Barba , Susan Helen Davis , Matthew Colin Thor Fyfe , Revathy Perpetua Jeevaratnam , Karen Lesley Schofield , Thomas Staroske , Alan John William Stewart , Simon Andrew Swain , David Matthew Withall
- Applicant Address: GB Oxford
- Assignee: PROSIDION LIMITED
- Current Assignee: PROSIDION LIMITED
- Current Assignee Address: GB Oxford
- Priority: GB0904287.0 20090312
- International Application: PCT/GB2010/050442 WO 20100312
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/4545 ; C07D401/14 ; A61P3/06 ; A61P3/00 ; A61P3/04 ; C07D413/14 ; A61K31/501 ; A61P3/10
Abstract:
The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes.
Information query
IPC分类:
